VT-214

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameVT-214
Drug Alias NameVT-200 seriesnon-selective chemokine binding proteins (Viron)CBP1VT-239VT-214
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionChemokine receptors antagonists
TargetsChemokine receptors
Therapy Area/IndicationsRejection of organ transplantationInflammationImmune System Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesViron Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViron Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationInflammationImmune System Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A